| Date Checked | 2025-12-21 23:41:13 |
|---|---|
| Graham Number | (PB)108.02 vs (PE)67.23 |
| Over / Under Value Percentage | 74.69% vs 112.45% |
| Dividend Yield | 2.08% |
| Dividend Date | 2025-12-31 |
| Symbol | BDX |
| AssetType | Common Stock |
| Name | Becton Dickinson and Company |
| Description | Becton, Dickinson and Company (BDX) is a leading American multinational medical technology company renowned for its development and production of critical medical devices, instrument systems, and reagents that significantly improve global healthcare outcomes. With a diversified portfolio that supports a wide array of diagnostic and therapeutic procedures, BDX effectively addresses the evolving needs of the healthcare community while providing analytical and consulting services to enhance its operational footprint. Driven by a robust commitment to innovation, underscored by considerable investments in research and development, BDX is poised to capitalize on emerging trends in the medical technology sector, solidifying its position as a key player in advancing healthcare solutions. |
| CIK | 10795 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | MEDICAL INSTRUMENTS & SUPPLIES |
| Address | 1 BECTON DRIVE, FRANKLIN LAKES, NJ, UNITED STATES, 07417-1880 |
| OfficialSite | https://www.bd.com |
| FiscalYearEnd | September |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 57580589000 |
| EBITDA | 6222000000 |
| PERatio | 34.46 |
| PEGRatio | 1.032 |
| BookValue | 88.96 |
| DividendPerShare | 4.16 |
| EPS | 5.83 |
| RevenuePerShareTTM | 75.93 |
| ProfitMargin | 0.0768 |
| OperatingMarginTTM | 0.179 |
| ReturnOnAssetsTTM | 0.0417 |
| ReturnOnEquityTTM | 0.0654 |
| RevenueTTM | 21839999000 |
| GrossProfitTTM | 10359000000 |
| DilutedEPSTTM | 5.83 |
| QuarterlyEarningsGrowthYOY | 0.252 |
| QuarterlyRevenueGrowthYOY | 0.083 |
| AnalystTargetPrice | 202.99 |
| AnalystRatingStrongBuy | 1 |
| AnalystRatingBuy | 4 |
| AnalystRatingHold | 9 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 34.46 |
| ForwardPE | 13.42 |
| PriceToSalesRatioTTM | 2.636 |
| PriceToBookRatio | 2.258 |
| EVToRevenue | 3.474 |
| EVToEBITDA | 15.31 |
| Beta | 0.277 |
| 52WeekHigh | 246.65 |
| 52WeekLow | 160.6 |
| 50DayMovingAverage | 188.71 |
| 200DayMovingAverage | 190.56 |
| SharesOutstanding | 285419000 |
| SharesFloat | 284662000 |
| PercentInsiders | 0.588 |
| PercentInstitutions | 94.291 |
| ExDividendDate | 2025-12-08 |
| dateChecked | 2025-12-21 23:41:13 |
| fresh | 1 |